Cargando…
An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect
BACKGROUND: Senile plaques consisting of amyloid-beta (Aβ) are the major pathological hallmark of Alzheimer’s disease (AD) and have been the primary therapeutic target. Immunotherapies, which are designed to remove brain Aβ deposits, increased levels of soluble Aβ and accelerated brain atrophy in so...
Autores principales: | Liu, Yu-Hui, Bu, Xian-Le, Liang, Chun-Rong, Wang, Ye-Ran, Zhang, Tao, Jiao, Shu-Sheng, Zeng, Fan, Yao, Xiu-Qing, Zhou, Hua-Dong, Deng, Juan, Wang, Yan-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551765/ https://www.ncbi.nlm.nih.gov/pubmed/26311039 http://dx.doi.org/10.1186/s12974-015-0379-4 |
Ejemplares similares
-
Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils
por: Ahmed, Mahiuddin, et al.
Publicado: (2010) -
Quantification and targeting of elusive neurotoxic amyloid oligomers
por: Bhatt, Nemil, et al.
Publicado: (2022) -
N-terminal
Domain of Amyloid-β
Impacts Fibrillation and Neurotoxicity
por: Shi, Jing-Ming, et al.
Publicado: (2022) -
Amyloid Oligomer Neurotoxicity, Calcium Dysregulation, and Lipid Rafts
por: Malchiodi-Albedi, Fiorella, et al.
Publicado: (2011) -
Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia
por: Sondag, Cindy M, et al.
Publicado: (2009)